|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM22161169X |
003 |
DE-627 |
005 |
20250214121454.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2012 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2012.09.005
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0738.xml
|
035 |
|
|
|a (DE-627)NLM22161169X
|
035 |
|
|
|a (NLM)23041503
|
035 |
|
|
|a (PII)S1521-6616(12)00230-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Siedlar, Maciej
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Commentary to the letter of Tjon et al
|
264 |
|
1 |
|c 2012
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 04.01.2013
|
500 |
|
|
|a Date Revised 02.12.2018
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a CommentOn: Clin Immunol. 2012 Oct;145(1):11-2. doi: 10.1016/j.clim.2012.07.008. - PMID 22885147
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Letter
|
650 |
|
4 |
|a Comment
|
650 |
|
7 |
|a Immunoglobulins, Intravenous
|2 NLM
|
650 |
|
7 |
|a Lipopolysaccharide Receptors
|2 NLM
|
650 |
|
7 |
|a Receptors, IgG
|2 NLM
|
700 |
1 |
|
|a Ziegler-Heitbrock, Loems
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 145(2012), 2 vom: 10. Nov., Seite 141
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:145
|g year:2012
|g number:2
|g day:10
|g month:11
|g pages:141
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2012.09.005
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 145
|j 2012
|e 2
|b 10
|c 11
|h 141
|